Researchers also highlighted the significance of TTNT-D as a real-world measure of treatment efficacy, noting it provides ...

It is important for people living with chronic lymphocytic leukemia (CLL) to take care of their mental and physical health. Tips to manage day-to-day include getting enough rest and talking with ...

Most people with CLL interact with a variety of healthcare professionals, including hematologists and medical oncologists. Depending on the type of therapy you receive, you may also work with a ...

Keep reading to learn more about how CLL is diagnosed and staged. At the start of your visit, a healthcare professional will perform a physical and medical history examination. According to the ...

In stage 0 CLL, treatment isn’t usually required. The primary medical approach is watchful waiting. During the watchful ...

If you have a loved one with CLL, you’ll want to know how best to help them. Here’s what you should know about treatments, support, and more.

CLL is the most prevalent type of leukaemia in ... and will present the data in full at a future medical meeting. Calquence is a second-generation BTK inhibitor, with greater selectivity than ...

SUV remains the most widely used PET parameter to evaluate NHLs because it is directly associated with lymphoma aggressiveness.

B-cell chronic lymphocytic leukemia (CLL) is the most prevalent leukemia in Western countries. The clinical course is highly variable, reflecting the heterogeneity of underlying phenotypes.

China's National Medical Products Administration has approved ... with orelabrutinib as a first-line therapy for chronic lymphocytic leukaemia (CLL)/small lymphocytic lymphoma (SLL).

highlighting emerging data that may refine their use in chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), particularly in optimizing treatment duration and sequencing to improve ...